A patient in the emergency department presents with poorly controlled asthma and signs of an exacerbation. After initiating systemic corticosteroids and high-flow oxygen therapy, the patient shows slight improvement. Which of the following nursing interventions is critical in assessing the effectiveness of the treatment and preventing future exacerbations?

D) Review the patient's inhaler technique and adherence to medication.

A) Monitor for changes in respiratory rate and effort.

B) Educate the patient on avoiding asthma triggers.

C) Schedule regular spirometry tests to assess lung function.

D) Review the patient's inhaler technique and adherence to medication.

A patient in the emergency department with a known history of asthma is presenting with worsening respiratory distress despite initial treatment with systemic corticosteroids and high-flow oxygen therapy. The patient now exhibits signs of respiratory acidosis and a possible superimposed bacterial infection. What is the most appropriate next step in managing this patient's respiratory status?

A) Initiate non-invasive ventilation

B) Increase the dose of corticosteroids

C) Administer a bronchodilator via nebulization

D) Start intravenous fluids for hydration

A 35-year-old female with a history of asthma presents to the emergency department with worsening respiratory distress, despite initial treatment with systemic corticosteroids and high-flow oxygen. Her arterial blood gas analysis shows a pH of 7.28, PaCO2 of 52 mmHg, and PaO2 of 60 mmHg. Auscultation reveals wheezing and crackles, and her white blood cell count is elevated. Which immediate nursing intervention is most appropriate to address her current respiratory status?

B) Prepare for non-invasive positive pressure ventilation (NIPPV).

A) Increase the flow rate of her oxygen therapy.

B) Prepare for non-invasive positive pressure ventilation (NIPPV).

C) Encourage the patient to perform pursed-lip breathing.

D) Administer a bronchodilator via a metered-dose inhaler.

A patient with asthma exacerbation is showing signs of acute respiratory distress syndrome (ARDS) with bilateral pulmonary infiltrates and worsening hypoxemia. Despite high-flow oxygen therapy, her condition continues to deteriorate. What is the most appropriate next step in managing her respiratory status?

B) Initiate non-invasive ventilation (NIV)

A) Increase the oxygen flow rate

B) Initiate non-invasive ventilation (NIV)

C) Administer bronchodilators more frequently

D) Prepare for immediate intubation and mechanical ventilation

A patient with a known history of asthma is experiencing severe respiratory distress, fatigue, and cyanosis despite receiving high-flow oxygen therapy and broad-spectrum antibiotics. The clinical team suspects acute respiratory distress syndrome (ARDS) due to bilateral infiltrates on a chest X-ray. Non-invasive ventilation (NIV) is initiated. Which nursing intervention is most critical to prioritize at this time?

A) Monitor arterial blood gas results to evaluate the effectiveness of the NIV.

B) Administer sedatives to the patient to reduce anxiety and improve comfort.

C) Increase the flow rate of the oxygen therapy to maximize oxygen delivery.

D) Encourage the patient to perform deep breathing exercises to improve lung expansion.

A patient with respiratory compromise shows partial improvement with non-invasive ventilation but remains hypoxemic and hypotensive. Which nursing intervention should be prioritized to address her current condition?

B) Prepare for intubation and mechanical ventilation to secure the airway.

A) Increase the flow rate of oxygen to improve oxygen saturation.

B) Prepare for intubation and mechanical ventilation to secure the airway.

C) Administer a fluid bolus to improve blood pressure and perfusion.

D) Reassess the effectiveness of antibiotic therapy and consider escalation.

A patient with respiratory acidosis and hypoxemia is showing signs of septic shock with hypotension and elevated inflammatory markers. Which of the following interventions should the nurse prioritize to stabilize the patient while addressing respiratory compromise and hemodynamic instability?

C) Prepare the patient for intubation and mechanical ventilation.

A) Initiate vasopressor support to maintain adequate blood pressure.

B) Administer a high-dose corticosteroid to reduce inflammation.

C) Prepare the patient for intubation and mechanical ventilation.

D) Increase the FiO2 on the high-flow oxygen to improve oxygenation.

A patient is experiencing worsening respiratory distress, hypoxemia, and hypotension despite high-flow oxygen therapy, with arterial blood gases indicating respiratory acidosis. Which of the following interventions should the nurse prioritize to stabilize the patient's condition?

B) Initiate mechanical ventilation

A) Increase the flow rate of oxygen therapy

B) Initiate mechanical ventilation

C) Administer a sedative to reduce agitation

D) Start intravenous fluids to improve blood pressure

A 68-year-old patient with worsening respiratory distress and hypotension is being assessed. Her recent arterial blood gas shows a pH of 7.28, PaCO2 of 60 mmHg, and PaO2 of 54 mmHg. The healthcare team has decided to initiate mechanical ventilation and vasopressor therapy. What is the nurse's priority action before starting mechanical ventilation?

C) Prepare and administer the prescribed sedation and analgesia.

A) Administer a fluid bolus to address hypotension.

B) Obtain informed consent for mechanical ventilation.

C) Prepare and administer the prescribed sedation and analgesia.

D) Notify the family about the patient's critical condition.

asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Airway inflammation - Asthma is characterized by chronic inflammation of the airways, leading to swelling and increased mucus production, which causes airway narrowing and obstruction, especially during an asthma attack.

• Secondary mechanism: Bronchial hyperresponsiveness - The inflamed airways become overly responsive to various triggers such as allergens, smoke, or cold air, resulting in bronchospasm where the bronchial muscles contract, further narrowing the airways and causing difficulty in breathing.

• Key complication: Airway remodeling - Over time, persistent inflammation and bronchial hyperresponsiveness can lead to structural changes in the airway walls, such as thickening and fibrosis, which may result in a decline in lung function and increased severity of asthma symptoms.

Patient Profile

Demographics:

45-year-old female, school teacher

History:

• Key past medical history: Asthma diagnosed 10 years ago, seasonal allergic rhinitis

• Current medications: Albuterol inhaler as needed, Fluticasone inhaler daily, Montelukast 10 mg daily

• Allergies: Penicillin, pollen

Current Presentation:

• Chief complaint: Increased shortness of breath and wheezing over the past week

• Key symptoms: Persistent cough, chest tightness, difficulty breathing during exertion, mild fatigue

• Vital signs: Blood pressure 138/86 mmHg, heart rate 102 bpm, respiratory rate 24 breaths per minute, temperature 98.6°F, oxygen saturation 92% on room air

Section 1

In the emergency department, further assessment of the patient reveals diminished breath sounds bilaterally with expiratory wheezing more pronounced in the upper lobes. Despite the use of her rescue inhaler, her symptoms have progressively worsened, indicating the need for additional medical intervention. A chest X-ray is performed and shows hyperinflation of the lungs but no signs of pneumothorax or consolidation. Given her history and current presentation, this suggests poorly controlled asthma with possible exacerbation due to seasonal allergens.

Blood tests reveal elevated eosinophil counts, consistent with an allergic component exacerbating her asthma. Her arterial blood gas analysis shows mild respiratory acidosis with a pH of 7.32, PaCO2 of 48 mmHg, and PaO2 of 65 mmHg, indicating impaired gas exchange and possible early respiratory failure if the condition progresses. Spirometry conducted after administration of a bronchodilator reveals a significant decrease in FEV1, with values at 60% of the predicted normal, confirming a severe airflow obstruction.

The clinical team decides to escalate her treatment by administering systemic corticosteroids and initiating high-flow oxygen therapy to improve her oxygen saturation. Continuous monitoring reveals a slight improvement in her oxygen saturation to 95%, and her respiratory rate decreases to 20 breaths per minute. However, the persistence of wheezing and her history of airway remodeling raise concerns about potential permanent changes in her lung structure, necessitating a comprehensive review of her long-term asthma management plan to prevent future exacerbations and complications.

Section 2

The patient's response to the initial interventions of systemic corticosteroids and high-flow oxygen therapy shows some positive signs, as indicated by improved oxygen saturation levels and a decreased respiratory rate. However, during the subsequent hours in the emergency department, the patient's condition reveals new developments. She reports increased fatigue and difficulty in speaking full sentences, suggesting escalating respiratory distress. Vital signs show a heart rate of 110 beats per minute, blood pressure of 130/85 mmHg, and an elevated respiratory rate of 28 breaths per minute despite the oxygen support. Auscultation now reveals not only persistent wheezing but also the emergence of crackles in the lower lobes, prompting concerns about fluid accumulation or potential infection.

A repeat arterial blood gas (ABG) analysis is performed to reassess her respiratory status. The results show a worsening of the respiratory acidosis, with a pH dropping to 7.28, PaCO2 rising to 52 mmHg, and PaO2 decreasing to 60 mmHg. These findings suggest that despite oxygen supplementation, the patient is struggling with ventilation, indicating a potential need for escalation to non-invasive ventilation or even consideration of intubation if her condition continues to deteriorate. Additionally, her complete blood count (CBC) now reveals an elevated white blood cell count of 14,000/mm³, raising suspicions of a superimposed bacterial infection, possibly secondary to her compromised respiratory status.

Given these developments, the clinical team is prompted to initiate broad-spectrum antibiotics to address the possibility of an infectious process while considering further respiratory support options. This scenario emphasizes the need for vigilant monitoring and dynamic clinical reasoning to adjust the treatment plan swiftly, addressing both the acute exacerbation and emerging complications in her asthma management. The unfolding situation underscores the importance of a multidisciplinary approach to prevent progression to respiratory failure and to ensure the patient's stabilization.

Section 3

As the clinical team continues to monitor the patient closely, her condition takes another turn. Despite the initiation of broad-spectrum antibiotics and consideration of escalated respiratory support, her respiratory distress intensifies. Her fatigue deepens, and she becomes increasingly lethargic, a worrying sign that her body is struggling to maintain adequate oxygenation and ventilation. The patient's skin is cool and clammy, and she appears cyanotic around the lips and fingertips, indicating inadequate oxygen delivery to the tissues. Her heart rate climbs further to 120 beats per minute, and her respiratory rate remains elevated at 30 breaths per minute, despite high-flow oxygen therapy.

In response to her deteriorating condition, the clinical team performs a chest X-ray, which reveals bilateral infiltrates consistent with pulmonary edema, raising concerns about acute respiratory distress syndrome (ARDS) as a complication of her asthma exacerbation. Additionally, the crackles heard on auscultation suggest fluid accumulation in the lungs, likely exacerbating her respiratory compromise. This finding aligns with the worsening arterial blood gas results, indicating the urgent need for more aggressive intervention.

Given these developments, the decision is made to initiate non-invasive ventilation (NIV) to support her breathing and improve gas exchange. The team continues to reassess her response to treatment, focusing on maintaining adequate oxygenation and ventilation while closely monitoring for any signs of further deterioration. The possibility of intubation is kept at the forefront of considerations, should her condition fail to stabilize with current interventions. This scenario requires the healthcare team to engage in critical clinical reasoning, balancing the need for aggressive respiratory support with the risks associated with invasive procedures, while also addressing the underlying infectious process with targeted antibiotic therapy.

Section 4

As the clinical team continues to monitor the patient, her response to non-invasive ventilation shows some initial improvement, with a slight decrease in respiratory rate to 26 breaths per minute and a modest improvement in her oxygen saturation, now at 92% on high-flow oxygen. However, her heart rate remains elevated at 118 beats per minute, and she still exhibits signs of fatigue and lethargy. Arterial blood gas analysis reveals a pH of 7.32, PaCO2 of 55 mmHg, and PaO2 of 58 mmHg, indicating persistent respiratory acidosis and hypoxemia, despite the respiratory support. These findings suggest that while the NIV has provided some relief, it may not be sufficient to reverse her respiratory compromise entirely.

In light of these findings, the team considers the risk of progression to acute respiratory failure. The patient's blood pressure has also started to show a concerning trend, with recent measurements at 88/56 mmHg, raising the possibility of septic shock due to the underlying infectious process. Laboratory results show elevated inflammatory markers, including a white blood cell count of 15,000/mm^3 and a C-reactive protein level of 150 mg/L, supporting the diagnosis of a systemic inflammatory response. The team is now faced with the challenge of balancing aggressive respiratory support with hemodynamic stability, considering the need for vasopressor support.

Given the current situation, the healthcare team engages in critical discussions about the next steps in management. The possibility of intubation and mechanical ventilation is revisited, weighing the benefits of securing the airway and providing controlled ventilation against the risks of potential complications. Additionally, the team explores the need for adjusting antibiotic therapy based on culture results and considers the initiation of vasopressors to address the hypotension. This juncture requires careful clinical reasoning to prioritize interventions that will stabilize the patient while continuing to address the underlying causes of her deterioration.

Section 5

As the clinical team navigates the patient's complex situation, a change in her status becomes evident, prompting immediate reassessment of her condition. Despite the initial improvements with non-invasive ventilation, her respiratory distress worsens, with an increase in respiratory rate to 32 breaths per minute and a further decline in oxygen saturation to 88% despite continued high-flow oxygen therapy. Her heart rate remains elevated at 122 beats per minute, and she exhibits increasing agitation and confusion, suggesting worsening hypoxemia and potential carbon dioxide retention. The blood pressure, now reading 82/50 mmHg, indicates a further decline in hemodynamic stability, necessitating urgent intervention.

A repeat arterial blood gas analysis shows a pH of 7.28, PaCO2 of 60 mmHg, and PaO2 of 54 mmHg, reinforcing the presence of worsening respiratory acidosis and hypoxemia. Concurrently, the patient's urine output has decreased significantly, with only 20 mL over the past two hours, raising concerns about renal perfusion and the potential onset of acute kidney injury. The combination of these findings suggests a progression towards acute respiratory failure and possible septic shock, highlighting the need for escalated care.

In response to these developments, the healthcare team prioritizes securing the airway and providing mechanical ventilation to stabilize her respiratory status. The decision to initiate vasopressor therapy is also made to address the persistent hypotension, with norepinephrine being the chosen agent to improve her blood pressure and organ perfusion. Antibiotic therapy is adjusted based on preliminary culture results, ensuring targeted treatment of the suspected infection. The team remains vigilant, closely monitoring her response to these interventions while preparing for potential complications that may arise during this critical phase of her care.